A detailed history of Plancorp, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Plancorp, LLC holds 2,534 shares of NVO stock, worth $197,322. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,534
Previous 1,965 28.96%
Holding current value
$197,322
Previous $233,000 6.87%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$85.0 - $120.04 $48,365 - $68,302
569 Added 28.96%
2,534 $217,000
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $1,227 - $1,469
10 Added 0.51%
1,965 $280,000
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $199,625 - $265,723
1,955 New
1,955 $251,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $176B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Plancorp, LLC Portfolio

Follow Plancorp, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.